Barańska-Rybak Wioletta, Świerczewska Zuzanna, Lemiec Agnieszka, Walker Lee
Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdańsk, Poland.
La Estetica Clinic, Płock, Poland.
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024117. doi: 10.5826/dpc.1402a117.
Tear-through deformities can be a detectable sign of facial aging. Over recent years, minimally invasive procedures such as hyaluronic acid filler injections have been shown to be effective in improving this area. Malar edema is the accumulation of fluid over the malar eminence persisting for 1 month or more. Given its nature, the management remains problematic. The most commonly reported treatment modality is injection with hyaluronidase.
To determine the safety and efficacy of triamcinolone injection in the treatment of malar edema.
A total of 15 female patients with malar edema, with a mean age of 43.77 years, were treated with triamcinolone injections. The volume injected was chosen by the investigator. Prior to the triamcinolone injection, all patients had been treated with hyaluronidase, which turned out to be ineffective in all cases. Patients were asked to note all adverse effects.
Satisfactory results were achieved after a single treatment session for 14 patients and after two treatments for one patient. Overall, injections with triamcinolone were well tolerated and no adverse reactions were reported.
Injection with triamcinolone appears to be a safe and effective option for the management of malar edema following hyaluronic acid filler injection. Nevertheless, further research with larger patient groups is compulsory.
泪沟畸形可能是面部衰老的一个可察觉迹象。近年来，诸如透明质酸填充剂注射等微创程序已被证明在改善该区域方面有效。颧部水肿是指颧突上的液体积聚持续1个月或更长时间。鉴于其性质，治疗仍然存在问题。最常报道的治疗方式是注射透明质酸酶。
确定曲安奈德注射治疗颧部水肿的安全性和有效性。
总共15名平均年龄为43.77岁的颧部水肿女性患者接受了曲安奈德注射治疗。注射量由研究者选择。在注射曲安奈德之前，所有患者均已接受透明质酸酶治疗，但结果在所有病例中均无效。要求患者记录所有不良反应。
14名患者单次治疗后取得了满意的效果，1名患者经过两次治疗后取得满意效果。总体而言，曲安奈德注射耐受性良好，未报告不良反应。
曲安奈德注射似乎是透明质酸填充剂注射后颧部水肿管理的一种安全有效的选择。然而，必须对更大的患者群体进行进一步研究。
